NO970174L - 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner - Google Patents

2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner

Info

Publication number
NO970174L
NO970174L NO970174A NO970174A NO970174L NO 970174 L NO970174 L NO 970174L NO 970174 A NO970174 A NO 970174A NO 970174 A NO970174 A NO 970174A NO 970174 L NO970174 L NO 970174L
Authority
NO
Norway
Prior art keywords
carbon atoms
straight chain
dihydroquinolinyl
oxazolidinones
thio
Prior art date
Application number
NO970174A
Other languages
English (en)
Other versions
NO970174D0 (no
Inventor
Dieter Haebich
Andreas Stolle
Bernd Riedl
Martin Ruppelt
Stephan Bartel
Walter Guarnieri
Rainer Endermann
Hein-Peter Kroll
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO970174D0 publication Critical patent/NO970174D0/no
Publication of NO970174L publication Critical patent/NO970174L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Det blir beskrevet 2-okso- og 2-tio-l,2-dihydrochinoli- nyl-oksazolidinoner med den generelle formel (I) (I), hvor A står for et oksygen- eller svovelatom, D står for hydrogen eller for cykloalkyl med 3 til 6 karbonatomer, eller rettkjedet eller forgrenet alkoksykarbonyl med opp til 4 karbonatomer, eller eventuelt substituert rettkjedet eller forgrenet alkyl eller alkenyl med opp til 9 karbonatomer, eller for eventuelt substituert rettkjedet eller forgrenet acyl med opp til 5 karbonatomer, eller for en av gruppene med formelene -( CT )jj-NR10r11 , -( C0)c-NR^2-C0-Nr13r14 _ -Nr15-S02R^^, r1'7r18-N-S02-, 51*^-5(0);, eller -C0-R20 , E og L er like eller forskjellige og står for hydrogen, karboksy, halogen, cyano, formyl, trifluormetyl, nitro eller rettkjedet eller forgrenet alkyl med opp til 4 karbonatomer, R^ står for azido, hydroksy, eller for en gruppe med formel -OR^l, O-SOaR^^ eller -KR^SrS"! ^ og deres salter og isomerer. Det blir dessuten beskrevet en fremgangsmåte for fremstilling av forbindelsene samt deres anvendelse i legemidler, spesielt i antibakterielle legemidler.
NO970174A 1996-01-16 1997-01-15 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner NO970174L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19601265A DE19601265A1 (de) 1996-01-16 1996-01-16 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone

Publications (2)

Publication Number Publication Date
NO970174D0 NO970174D0 (no) 1997-01-15
NO970174L true NO970174L (no) 1997-07-17

Family

ID=7782816

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970174A NO970174L (no) 1996-01-16 1997-01-15 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner

Country Status (28)

Country Link
US (1) US5861413A (no)
EP (1) EP0785197A3 (no)
JP (1) JPH09194478A (no)
KR (1) KR970059174A (no)
AR (1) AR005458A1 (no)
AU (1) AU711924B2 (no)
BG (1) BG62257B1 (no)
BR (1) BR9700688A (no)
CA (1) CA2194945A1 (no)
CO (1) CO4520188A1 (no)
CZ (1) CZ12897A3 (no)
DE (1) DE19601265A1 (no)
EE (1) EE9700019A (no)
HN (1) HN1996000124A (no)
HR (1) HRP960614A2 (no)
HU (1) HUP9700126A3 (no)
IL (1) IL119994A0 (no)
NO (1) NO970174L (no)
NZ (1) NZ314057A (no)
PE (1) PE35398A1 (no)
PL (1) PL317930A1 (no)
SG (1) SG46764A1 (no)
SK (1) SK5897A3 (no)
SV (1) SV1997000002A (no)
TN (1) TNSN97009A1 (no)
TR (1) TR199601002A1 (no)
YU (1) YU1097A (no)
ZA (1) ZA97302B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
BR9907183A (pt) 1998-01-23 2003-06-10 Versicor Inc Colet neas combinatórias de oxazolidinona, composições e processos de preparação
AU753988B2 (en) 1998-06-05 2002-10-31 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
MY127336A (en) * 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DK1301207T3 (da) 2000-06-30 2005-10-10 Pharmacia & Upjohn Co Llc Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin
ATE319710T1 (de) 2000-12-21 2006-03-15 Pharmacia & Upjohn Co Llc Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
WO2004014897A1 (en) * 2002-08-12 2004-02-19 Pharmacia & Upjohn Company Llc N-aryl-2-oxazolidinones and their derivatives
WO2004026848A1 (en) * 2002-09-20 2004-04-01 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
AR042086A1 (es) * 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
ES2312839T3 (es) * 2002-12-04 2009-03-01 Glaxo Group Limited Quinolinas y sus derivados nitrogenados y su uso como agentes antibacterianos.
JP2006516991A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤
EP1594494A1 (en) * 2003-02-07 2005-11-16 Warner-Lambert Company LLC Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
BRPI0409955A (pt) 2003-04-30 2006-04-25 Morphochem Ag Komb Chemie uso de antibióticos hìbridos de oxazolidinona - quinolina para o tratamento de antrax e outras infecções
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
KR101176450B1 (ko) 2003-12-18 2012-08-30 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 옥사졸리디논-퀴놀론 혼성 항생제
US7494578B2 (en) * 2004-03-01 2009-02-24 Atotech Deutschland Gmbh Iron-phosphorus electroplating bath and method
US20080262056A1 (en) * 2004-08-06 2008-10-23 Pfizer Inc Oxindole Oxazolidinones as Antibacterial Agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
WO2009104159A1 (en) * 2008-02-22 2009-08-27 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives
US10160726B2 (en) * 2014-08-06 2018-12-25 Novartis Ag Quinolone derivatives as antibacterials
KR20220055171A (ko) * 2020-10-26 2022-05-03 주식회사 아이비스바이오 포말리도마이드로부터 3,6'-디티오포말리도마이드를 선택적으로 합성하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
DE68918792T2 (de) * 1988-09-15 1995-03-30 Upjohn Co 5-Indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(Nitrogen-substituierte)phenyl-5-beta-amidomethyloxazolidin-2-one.
JP2669579B2 (ja) 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4332384A1 (de) 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (no) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone

Also Published As

Publication number Publication date
CA2194945A1 (en) 1997-07-17
PE35398A1 (es) 1998-08-29
CO4520188A1 (es) 1997-10-15
ZA97302B (en) 1997-07-17
AU711924B2 (en) 1999-10-21
TR199601002A1 (tr) 1997-08-21
JPH09194478A (ja) 1997-07-29
BG101131A (en) 1998-04-30
EE9700019A (et) 1997-08-15
CZ12897A3 (en) 1997-08-13
HN1996000124A (es) 1997-06-18
EP0785197A2 (de) 1997-07-23
HUP9700126A2 (hu) 1998-12-28
KR970059174A (ko) 1997-08-12
DE19601265A1 (de) 1997-07-17
TNSN97009A1 (fr) 2005-03-15
HRP960614A2 (en) 1998-02-28
HU9700126D0 (en) 1997-02-28
BR9700688A (pt) 1998-09-01
NZ314057A (en) 1998-11-25
HUP9700126A3 (en) 1999-05-28
IL119994A0 (en) 1997-04-15
SV1997000002A (es) 1997-08-29
EP0785197A3 (de) 1999-02-10
AU1009797A (en) 1997-07-24
PL317930A1 (en) 1997-07-21
US5861413A (en) 1999-01-19
MX9700419A (es) 1997-07-31
AR005458A1 (es) 1999-06-23
SK5897A3 (en) 1997-09-10
BG62257B1 (bg) 1999-06-30
YU1097A (sh) 1999-12-27
NO970174D0 (no) 1997-01-15
SG46764A1 (en) 1998-02-20

Similar Documents

Publication Publication Date Title
NO970174L (no) 2-okso- og 2-tio-1,2-dihydrochinolinyl-oksazolidinoner
ES2134847T3 (es) Derivados de taxol.
GB9508195D0 (en) Novel biologically active compounds and compositions,their use and derivation
MX9707980A (es) Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos.
AU584663B2 (en) Thieno-triazolo-1,4-diazepino-2-carboxylic acid amides
PA8484201A1 (es) Derivados de adenina
MX9710218A (es) Compuestos aromaticos y composiciones farmaceuticas que los contienen.
MXPA04005847A (es) Compuestos derivados de 4-sulfuro/sulfoxido/sulfonil-1h-pirazolilo, para uso en enfermedades asociadas con el receptor 5-ht2c.
DE69308029D1 (de) 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aBETA)-6-ISOCHINOLINAMINE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS THERAPEUTIKA
TR200103683T2 (tr) Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı
BG102701A (en) 2-hetaroylcyclohexan-1,3-dions
DE3869173D1 (de) Amino 5,6,7,8-tetrahydronaphtho(2,3b)furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
GB9711123D0 (en) Novel cyanoguanidines
ATE232081T1 (de) Orale zusammensetzung enthaltend perlit
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
BR0014687A (pt) Compostos de taxano pentacìclico
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
DE69819695D1 (en) Benzimidazolderivate
DE69509231D1 (de) 3-substituierte pyridinverbindungen und deren derivate als herbizide
DE69801811D1 (de) Alkykendiamin di- oder tri-essigsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen zusammensetzungen
DK0686641T3 (da) 2'-Deoxy-5-fluoruridinderivat, farmaceutisk acceptabelt salt deraf, fremgangsmåde til fremstilling deraf, og antitumorlægem
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf